State Street Corp Vir Biotechnology, Inc. Transaction History
State Street Corp
- $2.59 Trillion
- Q2 2025
A detailed history of State Street Corp transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, State Street Corp holds 5,254,712 shares of VIR stock, worth $22.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,254,712
Previous 5,727,163
8.25%
Holding current value
$22.9 Million
Previous $37.1 Million
28.64%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding VIR
# of Institutions
243Shares Held
109MCall Options Held
342KPut Options Held
165K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$72.7 Million0.67% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$71.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.2MShares$57.7 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL12.9MShares$56.3 Million34.47% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.46MShares$15.1 Million0.0% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $578M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...